IBT.V Stock - IBEX Technologies Inc.
Unlock GoAI Insights for IBT.V
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | $7.49M | $7.89M | $5.31M | $5.21M | $4.31M |
| Gross Profit | $5.20M | $5.36M | $3.03M | $2.97M | $1.36M |
| Gross Margin | 69.4% | 67.9% | 57.2% | 57.0% | 31.5% |
| Operating Income | $-1,480,579 | $2.27M | $855,480 | $707,377 | $-1,378,108 |
| Net Income | $3.89M | $1.67M | $761,503 | $965,689 | $-1,267,682 |
| Net Margin | 52.0% | 21.2% | 14.4% | 18.5% | -29.4% |
| EPS | $0.16 | $0.07 | $0.03 | $0.04 | $-0.05 |
IBEX Technologies Inc., through its subsidiaries, manufactures and markets enzymes for biomedical use in Canada, the United States, Germany, the United Kingdom, and internationally. It offers a portfolio of recombinant glycosaminoglycan lyases, including Heparinase I, Heparinase II, Heparinase III, Chondroitinase AC, and Chondroitinase B; collagen ELISAs for the study of synthesis and degradation of connective tissue components; collagen antibodies; and diamine oxidase liquid. The company also manufactures and markets a range of arthritis assays, which are used in osteoarthritis research. In addition, it provides lyophilization services for making disposable medical device components; and custom fermentation and contract manufacturing services. It serves manufacturers of medical devices, quality control labs, low molecular weight heparin manufacturers, and academic research institutions. IBEX Technologies Inc. was incorporated in 1972 and is based in Montreal, Canada.
Visit WebsiteEarnings History & Surprises
IBT.VEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2025 | Mar 20, 2025 | — | — | — | — |
Q4 2024 | Dec 12, 2024 | — | — | — | — |
Q2 2024 | Jun 5, 2024 | — | — | — | — |
Q1 2024 | Mar 18, 2024 | — | $0.00 | — | — |
Q4 2023 | Dec 14, 2023 | — | $0.03 | — | — |
Q4 2023 | Nov 9, 2023 | — | $0.09 | — | — |
Q2 2023 | Jun 7, 2023 | — | $0.04 | — | — |
Q1 2023 | Mar 20, 2023 | — | $0.00 | — | — |
Q4 2022 | Dec 8, 2022 | — | $0.00 | — | — |
Q4 2022 | Oct 31, 2022 | — | $0.03 | — | — |
Q2 2022 | Apr 30, 2022 | — | $0.02 | — | — |
Q1 2022 | Jan 31, 2022 | — | $0.02 | — | — |
Q4 2021 | Oct 31, 2021 | — | $0.03 | — | — |
Q3 2021 | Jul 31, 2021 | — | $0.01 | — | — |
Q2 2021 | Apr 30, 2021 | — | $0.01 | — | — |
Q1 2021 | Jan 31, 2021 | — | $0.01 | — | — |
Q4 2020 | Oct 31, 2020 | — | $0.00 | — | — |
Q3 2020 | Jul 31, 2020 | — | $0.01 | — | — |
Q2 2020 | Apr 30, 2020 | — | $0.02 | — | — |
Q1 2020 | Jan 31, 2020 | — | $-0.00 | — | — |
Latest News
Frequently Asked Questions about IBT.V
What is IBT.V's current stock price?
What is the analyst price target for IBT.V?
What sector is IBEX Technologies Inc. in?
What is IBT.V's market cap?
Does IBT.V pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to IBT.V for comparison